Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Wagner

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2015
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trialGuillem Argilés, Mark P Saunders, Fernando Rivera, et al.
Lancet (London, England)|November 27, 2012
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trialAxel Grothey, Eric Van Cutsem, Alberto Sobrero, et al.
The Lancet. Oncology|July 18, 2015
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trialJosep Tabernero, Heinz-Josef Lenz, Salvatore Siena, et al.
Journal of Pediatric Surgery|May 21, 2018
A descriptive model for a multidisciplinary unit for colorectal and pelvic malformationsAlejandra Vilanova-Sanchez, Devin R Halleran, Carlos A Reck-Burneo, et al.
Science Translational Medicine|February 25, 2021
Load-induced regulation of tendon homeostasis by SPARC, a genetic predisposition factor for tendon and ligament injuriesTao Wang, Andrea Wagner, Renate Gehwolf, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2015
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trialGuillem Argilés, Mark P Saunders, Fernando Rivera, et al.
Lancet (London, England)|November 27, 2012
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trialAxel Grothey, Eric Van Cutsem, Alberto Sobrero, et al.
The Lancet. Oncology|July 18, 2015
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trialJosep Tabernero, Heinz-Josef Lenz, Salvatore Siena, et al.
Journal of Pediatric Surgery|May 21, 2018
A descriptive model for a multidisciplinary unit for colorectal and pelvic malformationsAlejandra Vilanova-Sanchez, Devin R Halleran, Carlos A Reck-Burneo, et al.
Science Translational Medicine|February 25, 2021
Load-induced regulation of tendon homeostasis by SPARC, a genetic predisposition factor for tendon and ligament injuriesTao Wang, Andrea Wagner, Renate Gehwolf, et al.
Pageof 10